ReviewAmerican journal of human genetics2026
Incorporating polygenic risk scores and social determinants of health across populations: Considerations and best practices in research.
Review in American journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Breast cancer polygenic risk score performance varies by socioeconomic status.medRxiv : the preprint server for health sciences · 2026Article
- Polygenic risk score translation across diverse populations.Frontiers in cardiovascular medicine · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
There is a growing interest in evaluating the intersection of genetic and environmental factors, particularly social determinants of health (SDoH). As both the distributions and associations of genetic and SDoH-related risk vary across populations, a thorough understanding of the interplay of these factors (genetics and SDoH across populations) is necessary for the appropriate design and interpretation of studies examining their combined impact on health outcomes. In this review, we review population descriptors, including self-reported social constructs and genetically defined constructs, highlighting the different concepts they may capture and when it may be appropriate to use them. We discuss the challenges of applying polygenic risk scores (PRSs) to populations distinct in their genetic architecture or social context from the cohort in which they were developed. We provide an overview of conceptual SDoH frameworks and measures at the individual and area levels, discussing how these measures are defined, assessed, utilized, and interpreted in health research. For evaluating SDoH and PRS jointly, we outline analytic considerations, including calculating main-effect estimates, conducting gene-environment interaction studies, testing for mediation, and incorporating these factors into clinical prediction algorithms. When examining across populations, we highlight opportunities and challenges of data harmonization across existing cohorts and biobanks and ethical considerations necessary before embarking on or reporting work in this field. In all cases, we highlight the criticality of basing scientific questions upon well-considered conceptual frameworks arising from prior established relationships between risk factors and disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.